News

Latest News

06/15/2022

Alvotech, a Global Pureplay Biosimilars Company, to Debut on Nasdaq Under the Ticker ALVO on June 16

06/07/2022

Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination

06/03/2022

Oaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Alvotech

12/07/2021

Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company
> Investor Presentation

01/20/2021

Hims & Hers Health, Inc. Closes Business Combination and Will Begin Trading on the New York Stock Exchange

01/12/2021

Oaktree Acquisition Corp. Announces Extraordinary General Meeting Teleconference Details

01/06/2021

Oaktree Acquisition Corp. Reminds Shareholders to Vote in Favor of the Business Combination with Hims & Hers

11/09/2020

Oaktree Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing November 9, 2020

10/29/2020

Hims & Hers Announces Q3 Update

10/01/2020

Hims & Hers, a Multi-Specialty Telehealth Platform, to Become Publicly-Traded via Merger with Oaktree Acquisition Corp.
> Investor Presentation

09/21/2020

Oaktree Acquisition Corp. II Announces Closing of Initial Public Offering and Partial Exercise of Overallotment Option

09/16/2020

Oaktree Acquisition Corp. II Announces Pricing of $225 Million Initial Public Offering

09/06/2019

Oaktree Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants Commencing September 9, 2019

07/22/2019

Oaktree Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Overallotment Option

07/17/2019

Oaktree Acquisition Corp. Announces Pricing of $175 Million Initial Public Offering